Shuchismita Dutta (@sd_viz) 's Twitter Profile
Shuchismita Dutta

@sd_viz

Science Communicator and Global Health advocate; Storyteller, combining multi-disciplinary perspectives with molecular visualization; AAAS Fellow.

ID: 4418763263

linkhttps://oirap.rutgers.edu/facsurv/html/Shuchismita_Dutta.html calendar_today08-12-2015 19:20:41

948 Tweet

233 Followers

81 Following

Shuchismita Dutta (@sd_viz) 's Twitter Profile Photo

In October U.S. FDA approved inavolisib, a PI3Kα Inhibitor to treat locally advanced or metastatic breast #Cancer. It was approved for use with with palbociclib and fulvestrant.

In October <a href="/US_FDA/">U.S. FDA</a> approved inavolisib, a PI3Kα Inhibitor to treat locally advanced or metastatic breast #Cancer. It was approved for use with with palbociclib and fulvestrant.